Phenoxymethylpenicillin 250mg tablets

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Phenoxymethylpenicillin potassium

Boleh didapati daripada:

Phoenix Healthcare Distribution Ltd

Kod ATC:

J01CE02

INN (Nama Antarabangsa):

Phenoxymethylpenicillin potassium

Dos:

250mg

Borang farmaseutikal:

Oral tablet

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Valid as a prescribable product

Ringkasan produk:

BNF: 05010101

Risalah maklumat

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
PHENOXYMETHYLPENICILLIN POTASSIUM
TABLETS 250MG
READ
ALL
OF
THIS
LEAFLET
CAREFULLY
BEFORE
YOU
START
TAKING
THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
•
If any of the side effects get serious, or if you notice any side
effects
not listed in this leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET:
1.
WHAT PHENOXYMETHYLPENICILLIN POTASSIUM IS AND WHAT IT IS USED FOR
2.
BEFORE YOU TAKE PHENOXYMETHYLPENICILLIN POTASSIUM
3.
HOW TO TAKE PHENOXYMETHYLPENICILLIN POTASSIUM
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE PHENOXYMETHYLPENICILLIN POTASSIUM
6.
FURTHER INFORMATION
1.
WHAT
PHENOXYMETHYLPENICILLIN
POTASSIUM
IS
AND
WHAT IT IS USED FOR
Phenoxymethylpenicillin
Potassium
is
one
of
a
group
of
antibiotic
medicines called penicillins. They are used to treat infections caused
by
bacteria that are sensitive to penicillins.
Phenoxymethylpenicillin Potassium is used to treat a range of
bacterial
infections:
•
Chest (bronchitis or pneumonia) infections
•
To treat ear and throat infections (such as otitis media and
pharyngitis)
•
To treat skin and soft tissue infections such as scarlet fever and
erysipelas
•
To prevent recurrent attacks of rheumatic fever
•
To prevent lung infections in patients with no spleen or sickle cell
disease.
2.
BEFORE YOU TAKE PHENOXYMETHYLPENICILLIN POTASSIUM
DO NOT TAKE PHENOXYMETHYLPENICILLIN TABLETS:
•
If
you
are
allergic
(hypersensitive)
to
phenoxymethylpenicillin
potassium
•
If you are allergic (hypersensitive) to any of the other ingredients
in
this medicine
•
If you are allergic (hypersensitive) to cephalosporin antibiotics
TAKE SPECIAL CARE WITH PHENOXYMETHYLPENICILLIN POTASSIUM
Tell your doctor before you start to take this medicine if you:
•
Have a history of allergies
•
Have kidney dise

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Phenoxymethylpenicillin 250mg Tablets BP
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Phenoxymethylpenicillin potassium (1515 l-U/mg)
BP
280.00mg
3
PHARMACEUTICAL FORM
White, flat bevelled edge tablets, engraved on one side with company
logo and
with breakline and A057 on the other side
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Phenoxymethylpenicillin and potassium phenoxymethylpenicillin are
indicated in the
treatment of mild to moderately severe infections associated with
micro-organisms
whose susceptibility to penicillin is within the range of serum levels
attained with
these dosage forms. The following infections will usually respond to
adequate doses:
Streptococcal infections (without bacteraemia): Mild to moderate
infections of the
upper respiratory tract, scarlet fever and mild erysipelas.
Pneumococcal infections: Mild to moderately severe infections of the
respiratory
tract.
Staphylococcal infections sensitive to penicillin: Mild infections of
the skin and soft
tissues.
Fusospirochaetosis (Vincent’s gingivitis and pharyngitis): Mild to
moderately severe
infections of the oropharynx usually respond to therapy with oral
penicillin.
Prophylactic use: Prophylaxis with oral penicillin has proved
effective in preventing
reccurrence of rheumatic fever and chorea.
Patients with a past history of rheumatic fever receiving continuous
prophylaxis may
harbour penicillin-resistant organisms. In these patients, the use of
another
prophylactic agent should be considered.
Note: severe empyema, bacteraemia, pericarditis, meningitis and
arthritis should not
be treated with Phenoxymethylpenicillin during the acute phase.
Consideration should be given to official guidance on the appropriate
use of
antibacterial agent.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
125-500mg
every
4-6
hours
depending
on
the
severity
of
the
condition.
Prophylactic
use:
125mg
twice
daily
is
recommended
for
long
term
prophylaxis of rheumatic fever